Douglas B Johnson Selected Research

Douglas B Johnson Research Topics

Disease

161	Melanoma (Melanoma, Malignant) 06/2024 - 06/2013
142	Neoplasms (Cancer) 04/2024 - 06/2013
22	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2015
17	Myocarditis (Carditis) 01/2024 - 11/2016
11	Disease Progression 11/2023 - 12/2013
8	Inflammation (Inflammations) 10/2023 - 09/2015
8	COVID-19 03/2023 - 01/2020
7	Colitis 03/2024 - 01/2017
7	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2017
6	Pneumonia (Pneumonitis) 01/2021 - 11/2019
5	Uveal melanoma 10/2023 - 11/2016
5	Infections 03/2021 - 11/2018
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2014
4	Hypophysitis 01/2023 - 05/2015
4	Autoimmune Diseases (Autoimmune Disease) 09/2022 - 02/2016
4	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2020
3	Carcinoma (Carcinomatosis) 01/2024 - 05/2017
3	Nausea 09/2023 - 11/2017
3	Myositis (Idiopathic Inflammatory Myopathies) 07/2023 - 01/2018
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023 - 01/2020
3	Skin Neoplasms (Skin Cancer) 10/2022 - 04/2018
3	Heart Failure 01/2022 - 11/2017
3	Neutropenia 03/2021 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2020 - 06/2015
3	Encephalitis (Encephalitis, Rasmussen) 04/2020 - 01/2019
3	Drug-Related Side Effects and Adverse Reactions 01/2020 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2017
2	Genetic Risk Score 03/2024 - 09/2023
2	Ulcerative Colitis 03/2024 - 09/2023
2	Turcot syndrome 12/2023 - 01/2023
2	Fever (Fevers) 09/2023 - 01/2019
2	Cytokine Release Syndrome 01/2023 - 09/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 10/2019
2	Hypertension (High Blood Pressure) 01/2022 - 10/2019
2	Diarrhea 01/2022 - 01/2017
2	Obesity 01/2022 - 01/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 02/2016
2	Hepatitis 01/2021 - 12/2019
2	Immune System Diseases (Immune Disorders) 01/2021 - 11/2019
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2020 - 01/2020
2	Virus Diseases (Viral Diseases) 05/2020 - 01/2017
2	Myasthenia Gravis 04/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

117	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2013
34	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 06/2013
33	IpilimumabIBA 01/2023 - 12/2013
24	NivolumabIBA 04/2024 - 03/2015
19	AntibodiesIBA 01/2024 - 01/2016
19	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2014
17	LigandsIBA 01/2024 - 09/2015
13	pembrolizumabIBA 04/2024 - 01/2016
12	trametinibIBA 05/2024 - 06/2013
12	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2017
11	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2024 - 11/2014
11	dabrafenibIBA 05/2024 - 06/2013
11	SteroidsIBA 01/2023 - 11/2017
9	B7-H1 AntigenIBA 11/2023 - 03/2015
9	Programmed Cell Death 1 ReceptorIBA 10/2023 - 01/2018
9	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 05/2015
8	Mitogen-Activated Protein KinasesIBA 01/2022 - 06/2013
8	VemurafenibIBA 01/2021 - 06/2013
6	AntigensIBA 11/2022 - 01/2017
4	InterferonsIBA 11/2023 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2015
4	Phosphotransferases (Kinase)IBA 01/2019 - 09/2015
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2017
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 11/2016
3	Monoclonal AntibodiesIBA 01/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
3	CTLA-4 AntigenIBA 12/2021 - 01/2017
3	Interleukin-2 (IL2)IBA 02/2021 - 05/2014
3	atezolizumabIBA 01/2021 - 01/2018
3	talimogene laherparepvecIBA 09/2019 - 01/2015
3	Codon (Codons)IBA 01/2019 - 04/2015
2	Immune Checkpoint ProteinsIBA 12/2023 - 01/2017
2	Hormones (Hormone)IBA 12/2022 - 05/2015
2	Imatinib Mesylate (Gleevec)FDA Link 11/2022 - 06/2013
2	Immunoconjugates (Immunoconjugate)IBA 10/2022 - 01/2019
2	CateninsIBA 01/2022 - 04/2016
2	binimetinibIBA 01/2022 - 01/2021
2	GlucocorticoidsIBA 11/2021 - 11/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2021 - 01/2021
2	Abatacept (Orencia)FDA Link 01/2021 - 01/2019
2	Cancer VaccinesIBA 10/2020 - 01/2016
2	Blocking AntibodiesIBA 01/2020 - 11/2016
2	ParaffinIBA 01/2019 - 10/2017
2	Formaldehyde (Formol)FDA Link 01/2019 - 10/2017
2	HLA-DR Antigens (HLA-DR)IBA 11/2018 - 01/2016

Therapy/Procedure

161	Therapeutics 06/2024 - 06/2013
62	Immunotherapy 03/2024 - 09/2015
12	Drug Therapy (Chemotherapy) 01/2024 - 06/2013
4	Aftercare (After-Treatment) 01/2023 - 11/2016
4	Radiotherapy 01/2021 - 05/2015
2	Adjuvant Radiotherapy 06/2024 - 01/2023
2	Immunomodulation 12/2023 - 01/2023
2	Salvage Therapy 11/2023 - 01/2023
2	Injections 10/2023 - 01/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2017
2	Intralesional Injections 09/2019 - 01/2015